Study finds low rates of baseline BMD testing among older women with breast cancer

[News]

Aromatase inhibitors (AIs)—drugs that stop the production of estrogen in women—are standard adjuvant therapy for post-menopausal women with hormone-receptor positive breast cancer.

More... (http://www.news-medical.net/news/20160714/Study-finds-low-rates-of-baseline-BMD-testing-among-older-women-with-breast-cancer.aspx)